Durham’s Brii Biosciences bets $100M to advance possible COVID therapy
Date Published:
As COVID-19 continues to mutate and affect millions of people worldwide, a biotech company with significant ties to the Triangle…
COVID-19
In search of a better face mask: NCSU uses new tech in push for improvements
Date Published:
by Laura Oleniacz
North Carolina State University researchers at the Textile Protection and Comfort Center (TPACC) are developing a test method to…
UNC researchers develop potential universal coronavirus vaccine
Date Published:
by Shantell M. Kirkendoll
Scientists at the University of North Carolina Gillings School of Global Public Health have developed a universal vaccine…
How NC Biotech Center has helped fight COVID-19 – grants, education and more
Date Published:
by Jim Shamp, NCBiotech Writer
This might be a good time to take note.
The fast evolution of the early…
SAS to provide free analytics training options for COVID researchers
Date Published:
Analytics leader SAS is increasing its support of COVID researchers through new, free analytics training options. A year ago, SAS provided free…
GSK receives double dose of good COVID-19 news for vaccine, antibody treatment
Date Published:
by WRAL TechWire — May 27, 2021
GlaxoSmithKline has received good news on two fronts in the battle against COVID-19,…
Durham biopharma lands $7M to develop ‘muco-trapping’ antibody platform
Date Published:
Inhalon Biopharma is developing a “muco-trapping” antibody platform that could be used to treat acute respiratory infections, including COVID-19, and the…
Execs at RDU’s big airlines increasingly confident of faster recovery for business travel
Date Published:
Scott Kirby, CEO of American Airlines states that business demand for travel has already started increasing, and he expects to…
Durham biopharma lands $7M to develop ‘muco-trapping’ antibody platform
Date Published:
by WRAL TechWire — May 26, 2021 .
Inhalon Biopharma is developing a “muco-trapping” antibody platform that could be used…